Hims & Hers review
FDA warning letters dated 9 September 2025, over the compounded-semaglutide business it has since left behind. Through the Hers front door, a mass-market brand now selling FDA-approved brand-name GLP-1s — Wegovy, Zepbound, Ozempic — instead of the compounded semaglutide it used to. The posted price is only half the bill: a required $149/mo membership sits on top of whatever the medication costs, so the real monthly number is roughly double what the landing page shows.
$149/mo Wegovy Pill + $149/mo membership (~$298/mo all-in)
- Six-factor Editors' Rating
- Source-based review
This review draws on the provider’s public pricing, terms and disclosures. No one on this desk is your clinician.
Hims & Hers at a glance
- Semaglutide
- $149/mo Wegovy Pill + $149/mo membership (~$298/mo all-in)
- Tirzepatide
- $299/mo Zepbound + $149/mo membership (~$448/mo all-in)
- Coverage
- Not available in all 50 states (list not published)
- Brand-name
- Yes
How we scored Hims & Hers
Each score comes out of Hims & Hers's published pricing, disclosures and oversight, and the six combine into the 76/100 Editors' Rating on our weighted six-factor framework. A commission never changes a provider's score.
Cost is unpredictable, premium, or hides behind a plan commitment.
Reasonable oversight, though some program details aren't fully public.
The headline rate obscures a plan requirement or a hidden step-up.
Bends around a caregiver's week and takes a mother's life stage seriously.
Standard support — enough to stay on track, not high-touch.
Easy to pause and cancel — important when a mother's plans shift.
How we verified this review
- Primary source
- The company's own site
The compounded era is over here: the catalog is brand now — Wegovy, Zepbound, Ozempic, Mounjaro and the oral Foundayo and Ozempic pills. What the 'from $X' figures leave out is the $149 monthly membership underneath them, which puts the Wegovy pill near $298 all-in and Zepbound near $448. It is not available in every state, and FDA warning letters from September 2025 attach to the earlier compounded business.
Pricing
| Medication | Price | Plan |
|---|---|---|
| Brand semaglutide | $188 → $298 | Wegovy Pill, with membershipListed from $149 a month for the medication alone. Every medication requires the $149 monthly membership, billed separately ($39 the first month), so a standing month is about $298 and the first about $188. |
| Brand semaglutide | $348 | Wegovy Pen, with membershipListed from $199 a month for the medication, plus the $149 membership. |
| Brand semaglutide | $298 | Ozempic Pill, with membershipListed from $149 a month for the medication, plus the $149 membership. Ozempic is approved for type 2 diabetes and is prescribed only to patients who meet clinical criteria. |
| Brand semaglutide | $348 | Ozempic pen, with membershipListed from $199 a month for the medication, plus the $149 membership. Approved for type 2 diabetes; eligibility is decided by the provider. |
| Brand tirzepatide | $448 | Zepbound vial or KwikPen, with membershipListed from $299 a month for the medication, plus the $149 membership. |
| Brand tirzepatide | $2048 | Zepbound or Mounjaro pen, with membershipEach listed at $1,899 a month for the medication, plus the $149 membership. Mounjaro is approved for type 2 diabetes. |
| Brand orforglipron | $298 | Foundayo pill, with membershipListed from $149 a month for the medication, plus the $149 membership. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Hims & Hers's public disclosures at last review and change often; confirm the current number on Hims & Hers's own site.
What we like
- Now selling FDA-approved brand-name medication (Wegovy, Zepbound, Ozempic) rather than compounded semaglutide
- An explicit women's entrance (Hers) and a polished app most mothers already trust
- Three pills on the menu — the Wegovy pill, the Ozempic pill and Foundayo — so a needle-averse first-timer has a way in
The caveats
- The posted 'from $149/mo' price is medication only — a required $149/mo membership (billed separately, $39 the first month) roughly doubles the real ongoing cost
- Not available in all 50 states, and no state list is published — check yours at the first screen
- The membership fee is not HSA or FSA eligible, only the medication is
- Carries FDA warning letters dated 9 September 2025 over the prior compounded-semaglutide business, before this pivot to brand-name product
- A volume-first model — ongoing clinical touch is lighter than a dedicated care team
Hims & Hers: brand-name GLP-1s through a familiar app, at roughly twice the posted price
Most mothers know Hims & Hers from its advertising long before they consider it for a GLP-1, and the weight-loss program it runs today — through the Hers front door for women — sells FDA-approved brand-name medication: the Wegovy pill and pen, Zepbound vials and KwikPens, plus Foundayo, Ozempic and the newer Ozempic pill. The compounded semaglutide it once sold is gone from the catalog. That is a real change, because a brand-name medication comes with the manufacturer's own labeling, including the pregnancy and breastfeeding sections your OB will want to read.
What the headline prices leave out is the membership. Every medication on the menu requires an active Weight Loss Membership at $39 for the first month and $149 a month after that, billed separately. The company's own footnote is plain about it: medication is not available without a membership, the posted price is medication only, and the membership does not include or guarantee a prescription.
The real monthly number
- Wegovy pill: from $149/month medication + $149 membership = about $298 a month
- Wegovy pen: from $199/month medication + $149 membership = about $348 a month
- Ozempic pill or Foundayo pill: from $149/month medication + $149 membership = about $298 a month
- Ozempic pen: from $199/month medication + $149 membership = about $348 a month
- Zepbound, vial or KwikPen: from $299/month medication + $149 membership = about $448 a month
- Zepbound or Mounjaro pen: $1,899/month medication + $149 membership = about $2,048 a month
- First month: the membership is $39, so a Wegovy-pill start runs about $188
- Included in the membership: a personalized plan, 24/7 messaging with licensed providers, side-effect support, dose adjustments, a smart scale on opt-in
Over a full year on the Wegovy pill that comes to roughly $3,470; on Zepbound, roughly $5,270. Those are "from" prices, so confirm what your prescribed dose costs before you count on them. Insurance isn't required and isn't used — the program is built for cash pay, and HSA and FSA questions are answered in the company's own FAQ. If you are weighing brand against compounded on cost alone, our breakdown of compounded vs. brand GLP-1s on a family budget lays out where the two lanes actually land each month.
What signing up asks of you
The program runs online: you answer an eligibility questionnaire, choose between pills and injections or ask for a provider recommendation, and a licensed provider decides what, if anything, to prescribe. The membership renews automatically each month. One detail on the Hers page is worth reading before you start: it notes the program is not available in all 50 states, so check your state at the first screen rather than assuming coverage.
Who it suits
Hims & Hers fits a mother who specifically wants an FDA-approved brand-name GLP-1, values a polished app with round-the-clock messaging, and has already budgeted the membership into the total. It is also one of the few places a needle-averse first-timer can start on a pill — the Wegovy pill, Foundayo and the Ozempic pill are all on the menu — which matters if a weekly injection is the thing standing between you and starting at all. Our Zepbound vs. Wegovy guide helps if you are choosing between the two brands.
The catches
- The posted price is half the bill: the $149 monthly membership is mandatory and separate
- Paying the membership does not guarantee a prescription
- Its weight-loss pages say nothing about pregnancy, breastfeeding or postpartum timing — raise it with the provider, and with your OB, before you start
- Not available in every state, by the company's own note
- The company received FDA warning letters dated September 9, 2025, over the compounded-semaglutide business it has since left behind
The bottom line
Hims & Hers is a mainstream way to get brand-name Wegovy or Zepbound without an insurance fight, with an app most mothers will find easy to live with. Just read every price on the page as medication only and add $149 a month before you compare it with anyone else. If a single all-in compounded price matters more than the brand name, HealthRX, a partner, lists $165 a month for semaglutide and $214 for tirzepatide, and our head-to-head with CoreAge Rx sets the two models side by side. For timing around a pregnancy or nursing, start with GLP-1s and pregnancy: the real data.
The bottom line for mothers
Best for: Mothers who want a familiar, women-facing consumer brand and are comfortable budgeting for a separate membership fee on top of the posted medication price.
Alternatives to Hims & Hers
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge RxCoreAge RxFeatured partner
The one program on our list whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on our list.
- Visit Wellorithm
Compounded semaglutide and tirzepatide, plus brand-name pens, sold in 49 states — but the compounded prices appear only once you start the intake, and the brand prices assume three months paid upfront.
Providers like Hims & Hers
Keep comparing Hims & Hers
Head-to-head & alternatives
Ranked boards
- The 2026 guide to the best GLP-1 for moms
- Best GLP-1 for women — PCOS & menopause
- Best GLP-1 for first-timers & beginners
- Cheapest GLP-1 without insurance
- Best GLP-1 after baby — postpartum providers ranked
- Best GLP-1 with insurance & coverage help
- Best GLP-1 providers for PCOS
- Best GLP-1 for perimenopause & menopause
- Cheapest tirzepatide online, month to month
- Cheapest semaglutide online, month to month
Hims & Hers, answered
- How much does Hims & Hers cost?
- Hims & Hers has no verified standard ongoing monthly cash price in our current records. Advertised offers may depend on the treatment, plan commitment, insurance or intake. Get a written all-in quote and confirm the billing interval and renewal rate before committing.
- Is Hims & Hers safe to use while breastfeeding?
- Discuss breastfeeding with your prescriber before starting treatment through Hims & Hers. Advice depends on the exact medicine and formulation, your treatment needs and your infant's circumstances; limited milk data do not establish infant safety. Oral and injectable products can have different labeling, and a compounded preparation needs its own assessment. Tell the clinician if you are pregnant or planning pregnancy so treatment and any stopping interval can be planned individually.
- Does Hims & Hers offer both semaglutide and tirzepatide?
- Hims & Hers discloses both semaglutide and tirzepatide options. Confirm the specific product, formulation, current availability in your state and eligibility with the provider; a listed menu does not mean either medicine is appropriate for you.
- Where does Hims & Hers rank for mothers?
- Hims & Hers takes 76/100 in our Editors' Rating, placing it #18. Six factors chosen for mothers feed that number. CoreAge Rx, a featured partner, is worth a side-by-side look.
Pricing, states and verification reflect Hims & Hers's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.